Gamida Cell Ltd GMDA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:06 AM EST
8.05quote price arrow down-0.38 (-4.51%)
Volume
203
Close
8.43quote price arrow down-0.53 (-5.92%)
Volume
886,852
52 week range
2.60 - 15.00

...

Loading . . .

KEY STATS

  • Open8.78
  • Day High9.21
  • Day Low8.03
  • Prev Close8.43
  • 52 Week High15.00
  • 52 Week High Date02/10/21
  • 52 Week Low2.60
  • 52 Week Low Date03/16/20
  • Market Cap497.29M
  • Shares Out58.99M
  • 10 Day Average Volume0.75M
  • Dividend-
  • Dividend Yield-
  • Beta2.04
  • 1 Year % Change79.74

RATIOS/PROFITABILITY

  • EPS (TTM)-1.17
  • P/E (TTM)-7.20
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-52.546M
  • ROE (MRQ)-100.68%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Gamida Cell Ltd News

There is no recent news for this security.

Latest GMDA News From Our Partners

QUOTE FINDER

Profile

MORE
Gamida Cell Ltd is an Israel-based clinical-stage biopharmaceutical company. The Company develops cell therapies that are designed to cure cancer and rare, serious hematologic diseases. The Company is leveraging its nicotinamide (NAM)-based cell expansion technology to develop a pipeline of products designed to address the limitations of cell therapies. The following are the Company's clinical pipeline products: NiCord, which is evaluated in a Phase III study in patients with...
Robert Blum
Non-Executive Chairman
Julian Adams Ph.D.
Chief Executive Officer
Tzvi Palash CPA
Chief Operating Officer
Shai Lankry CPA
Chief Financial Officer
Address
5 Nahum Hafzadi Street
Jerusalem
95484
Israel